Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

800px-a_tamiflu_oseltamivir_capsule

Judge allows $1.5 billion Tamiflu stockpiling lawsuit against Roche to go ahead

September 30, 2020 Research and Development Roche, Tamiflu

A Maryland federal judge denied Roche’s motion to throw out a lawsuit that alleges the company defrauded the US and …
News
amoeba

Brain-eating amoeba in Texas water supply kills six-year-old

September 30, 2020 Research and Development amoeba, brain eating ameoba

Officials in Texas have said it could take two to three months to disinfect the water supply in Lake Jackson …
News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

September 30, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

The coronavirus news this week focuses on the development of treatments to alleviate symptoms of the virus, as Australian biotech …
News
pharmafocus_october_2020

The October 2020 issue of Pharmafocus is available to read free online now!

September 29, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, October 2020, Pharmafocus, digital edition, pharma

The latest monthly edition of Pharmafocus is available to read for free online now! As the US sails past the …
News
european_commission_web

Jyseleca secures European approval in rheumatoid arthritis

September 28, 2020 Research and Development, Sales and Marketing Europe, Jyseleca, arthritis, pharma

The European Commission has awarded approval to Gilead and Galpagos for their oral JAK inhibitor Jyseleca (filgotinib) as a treatment …
News
nasal-spray-drawing

Novel prophylactic nasal spray reduced COVID-19 replication by 96% in animal studies

September 28, 2020 Research and Development, Sales and Marketing COVID-19, Ena Respiratory, Nasal Spray

Australian biotech Ena Respiratory has revealed new data demonstrating that its novel nasal spray almost halted replication of the SARS-CoV-2 …
News

Novartis’ Zolgensma hits regulatory hurdle after FDA asks to review another study

September 24, 2020 Research and Development FDA

The FDA has requested an additional study in older children being treated with Novartis’ Zolgensma in the review process for …
News
fda_21_4

FDA grants Emergency Use Authorization for first antibody point-of-care COVID-19 test

September 24, 2020 Research and Development

The FDA has issued an Emergency Use Authorization (EUA) for the first antibody (serology) point-of-care test for coronavirus.  This is …
News
1

Science community calls for transparency on AstraZeneca’s halted US COVID-19 vaccine trial

September 23, 2020 Research and Development AstraZeneca, COVID-19, Vaccine

The halting of AstraZeneca’s COVID-19 vaccine trial around the world was cause for much initial concern over the eventual safety …
News
credit_-_reuters

Fujifilm’s Avigan reduces recovery time in non-severe COVID-19 patients

September 23, 2020 Research and Development, Sales and Marketing

Fujifilm has announced promising new Phase 3 findings demonstrating that its antiviral therapy Avigan (favipravir) had a statistically significant impact …
News
fda_21

FDA set to announce stricter criteria for COVID-19 vaccines to receive Emergency Use Authorization

September 23, 2020 Research and Development

The FDA is set to release new guidelines that would raise safety and efficacy requirements required for a COVID-19 vaccine …
News
flu_shot_advertising

Contracting flu and COVID-19 simultaneously increases the risk of death, new study shows

September 23, 2020 Research and Development coronavirus vaccine, flu vaccine, vaccines

Public Health England has warned that catching seasonal flu and coronavirus at the same time could almost double the risk …
News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

September 23, 2020 Research and Development COVID-19, coronavirus

The coronavirus news this week largely focuses on clinical trial results, with Pfizer saying that participants in a late-stage trial …
News
merckincweb

Positive five-year Keytruda survival data revealed at ESMO in metastatic, PD-L1+ non-small cell lung cancer

September 22, 2020 Manufacturing and Production, Research and Development ESMO 2020, MSD, keytruda, pharma

MSD took the opportunity at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 to unveil new Phase 3 …
News
shutterstock_38078521

New Lenvima/Keytruda combo data in a range of cancers presented at ESMO 2020

September 21, 2020 Research and Development, Sales and Marketing Cancer, ESMO2020, Eisai, Lenvima, MSD, keytruda

New data from two studies investigating the combination of Eisai’s multiple receptor tyrosine kinase inhibitor Lenvima (lenvatinib) and MSD’s blockbuster …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026